Supply chains move slowly, and then all at once. The rewiring of global manufacturing away from single-country concentration — “China+1” — stopped being a boardroom slide and became purchase orders: an estimated $165 billion of investment committed toward Indian manufacturing capacity, from electronics assembly to speciality chemicals to defence supply chains. For equity investors the question is not whether the relocation is real. It is where in the market its value lands.

Why India, why now

The relocation needed a destination with scale, and only a few exist. India’s offer compounds several structural facts: the largest young workforce in the world (65% of the population under 35), a decade of logistics and power infrastructure build-out, production-linked incentive schemes that de-risk early capacity, and a domestic market large enough that export capacity is never stranded. The same formalisation that feeds the IPO pipeline — GST, digital payments, auditable books — makes Indian suppliers integrable into global compliance chains in a way they were not ten years ago.

An anchor manufacturer relocates one plant. Its supplier ecosystem — dozens of listed SMEs — receives the order book.

The beneficiaries skew small

Index-level exposure captures the headline manufacturers, which are analysed exhaustively and priced accordingly. The operating leverage sits below them: component makers, precision engineering shops, testing and certification firms, industrial consumables, logistics specialists — companies with hundreds of crores of market value receiving order books that can multiply their revenue base. Many are exactly the under-covered, under-owned SMID names where price discovery lags fundamentals; several of the group’s past anchor and pre-IPO positions — heat exchangers, EPC, power equipment — sit in this supply-chain layer.

Discipline against the theme

Themes are where diligence goes to die, so the process treats China+1 as a catalyst tag, not a thesis substitute. A supply-chain beneficiary still has to pass promoter review, governance screening and valuation like any other position — order books can be announced, delayed, renegotiated or lost, and incentive schemes carry policy risk. The theme tells us where to look. It never tells us what to pay.